Minimize Uncertainty – Make Informed Decisions – Succeed

Hematology

Hematology Today—March 2, 2026

March 2, 2026Nipocalimab,risto-cel,Heparin-induced thrombocytopenia,Pentixapharm,gene editing,warm autoimmune hemolytic anemia,Sickle Cell Disease,Fulcrum Therapeutics,BioPharma and Tech News,Pociredir,Beam Therapeutics,Penn Medicine,Bleximenib,Children’s Hospital of Philadelphia,Johnson & Johnson,Cadrenal Therapeutics,Bristol Myers Squibb,CAD-1005,C4 Therapeutics,thrombosis,Acute Myeloid Leukemia,luspatercept,Hematology News,cemsidomide,alpha-thalassemia,relapsed refractory multiple myeloma,CRISPR gene editing,Blackstone Life Sciences,hematopoietic stem cell transplantation,Oryzonessential thrombocythemia,iadademstat

This is a weekly update in Hematology, covering key regulatory actions,…

by LucidQuest

Artificial_Intelligence

AI in Healthcare and Digital Health Today—March 2, 2026

March 2, 2026Virtual Nodule Clinic,Sehhaty,Lung Cancer Prediction AI,YOU(th),BioPharma and Tech News,Pulmonary Nodules,Pediatric Central Nervous System Tumors,obesity,QXR-Detect,Anthropic,Chest X-Ray Computer-Aided Detection,Glioblastoma,MDR-001,pulmonary hypertension,Kobe University,type 2 diabetes,Walgreens,Acromegaly,Generate Biomedicines,AI in Healthcare and Digital Health,Great Ormond Street Hospital,Qure.ai,LifeArc,Daewoong,WelFAS,MindRank,Huawei,ChatGPT Health,RareArena,Citizen Health,PhawareOptellum,Cortical Labs

 This week’s AI in Healthcare and Digital Health update highlights…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Novartis Rhapsido (remibrutinib) goes “beyond CSU”

March 2, 2026clinical trials,Regulatory,immunology,dermatology,biopharma,BTK Inhibitors,Lucid Diligence Brief,payer access,allergy,food allergy,chronic urticariacatalysts

Lucid Diligence Brief: Novartis Rhapsido (remibrutinib) goes “beyond CSU”…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: BioNTech DualityBio BNT324 Phase 3 mCRPC

March 1, 2026Oncology,clinical trials,market access,ASCO,merck,prostate cancer,ADC,biopharma,Daiichi Sankyo,CMC,Lucid Diligence Brief,diligencesafety

Lucid Diligence Brief: BioNTech DualityBio BNT324 Phase 3 mCRPC Professional…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Earendil Labs & WuXi XDC collaboration

February 28, 2026Oncology,market access,Regulatory,Bispecific Antibodies,ADC,biopharma,CMC,Lucid Diligence Brief,diligence,licensing deals,payload-linker,CRDMOsupply chain risk

Lucid Diligence Brief: Earendil Labs & WuXi XDC collaboration Professional…

by Timos Papagatsias

AAAAI 2026_Preview_by_LucidQuest.pptx

AAAAI 2026 Preview: Key Allergy, Asthma and Immunology Highlights to Watch

February 27, 2026Our Insights,biologicsAI in healthcare,immunology,Asthma,Atopic Dermatitis,chronic rhinosinusitis,allergy,food allergy,Conference Previews,urticaria,Pharma CI,AAAAI2026

AAAAI 2026 at a Glance Get ready for AAAAI 2026. LucidQuest’s preview brings…

by LucidQuest

ESGO 2026_Preview_by_LucidQuest

ESGO 2026 Preview: Key Gynaecological Oncology Highlights to Watch

February 27, 2026Our Insights,strategyclinicaltrials,Conference Previews,Insights,AIinHealthcare,GynecologicOncology,OvarianCancer,EndometrialCancer,CervicalCancer,PrecisionMedicine,RealWorldEvidence,ESGO2026

ESGO 2026 at a Glance Get ready for ESGO 2026. LucidQuest’s preview brings…

by LucidQuest

ESGO 2026_Preview_by_LucidQuest

ESGO 2026 Preview: Key Gynaecological Oncology Highlights to Watch

February 27, 2026Our Insights,clinical trialsprecision medicine,AI in healthcare,real-world evidence,Ovarian Cancer,endometrial cancer,cervical cancer,Conference Previews,gynecologic oncology,Insights,ESGO2026

ESGO 2026 at a Glance Get ready for ESGO 2026. LucidQuest’s preview brings…

by LucidQuest

Respiratory

Respiratory Today—February 27, 2026

February 27, 2026Regeneron,MOLBREEVI,ENFLONSIA,Alpibectir,astrazeneca,clesrovimab,Ethionamide,gsk,PureTech Health,YolTech Therapeutics,merck,deupirfenidone,Aclaris Therapeutics,sanofi,Savara,35Pharma,Asthma,molgramostim,Atopic Dermatitis,Respiratory News,BioPharma and Tech News,Dupixent,tuberculosis,chronic obstructive pulmonary disease,pulmonary hypertension,Allergic fungal rhinosinusitis,vapendavir,respiratory syncytial virus,Dupilumab,Alpha-1 antitrypsin deficiency,BioVersys,Tessera Therapeutics,Idiopathic Pulmonary Fibrosis,Celea TherapeuticsAltesa BioSciences,Autoimmune pulmonary alveolar proteinosis

This week’s Respiratory update highlights regulatory milestones, late-stage…

by LucidQuest

Vaccines

Vaccines Today—February 27, 2026

February 27, 2026Latent Tuberculosis,Biofabri,Moderna,EuBiologics,BioPharma and Tech News,EuHZV,Chikungunya,Varicella-Zoster Virus,COVID-19,Pneumococcal Conjugate Vaccine,SK Bioscience,IDT Biologika,shingles,Vaxxas,Valneva,Seasonal Influenza,Vaccine news,Pandemic Avian Influenza,influenza,France SNDS,pregnancy,UFMG,Vaxcyte,Calixcoca,IAVI,Cocaine AddictionMRNA-1073,MTBVAC

This week’s Vaccines update highlights combination respiratory vaccine data,…

by LucidQuest

Public_Health

Public Health Video Recap—February 27, 2026

February 27, 2026Alzheimer's Disease,BioPharma and Tech News,Cardiovascular Disease,Glioma,Stanford Medicine,Public Health News,FNIH Biomarkers Consortium,ChatGPT Health,probiotics,PROMISE Trial,Chikungunya Virus Infection,Type 1 Diabetes MellitusArtificial Intelligence Triage,Mount Sinai Health System

This biweekly Public Health video recap highlights regulatory updates, clinical…

by LucidQuest

Public_Health

Public Health Today—February 27, 2026

February 27, 2026Clindamycin,Clostridioides Difficile,BioPharma and Tech News,Nuclear Power Plants,type 1 diabetes,Microplastics,Public Health News,ChatGPT Health,Mount Sinai,PROMISE Trial,Major Adverse Cardiovascular Events,Total Plaque Burden,Nature Medicine,NYU Langone,Womb Transplant UKMayer-Rokitansky-Kuster-Hauser Syndrome,Bifidobacterium Longum APC1472

This week’s Public Health update highlights sex-specific cardiovascular risk…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.